Profil
Siegmund Karasch is the founder of AdrenoMed AG.
He is currently a Member-Supervisory Board at Deutsche Biotech Innovativ AG since 2018.
Previously, he worked as Chief Executive & Operating Officer at InVivo BioTech Services GmbH.
He completed his undergraduate degree from Hochschule für Technik und Wirtschaft Berlin in 1993.
Postes actifs de Siegmund Karasch
| Sociétés | Poste | Début |
|---|---|---|
| DEUTSCHE BIOTECH INNOVATIV AG | Directeur/Membre du Conseil | 05/07/2018 |
Anciens postes connus de Siegmund Karasch
| Sociétés | Poste | Fin |
|---|---|---|
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology Develops a drug to decrease mortality in severe sepsis | Fondateur | 01/01/2014 |
InVivo BioTech Services GmbH
InVivo BioTech Services GmbH Medical SpecialtiesHealth Technology Manufactures analytical and medical instruments | Directeur Général | - |
Formation de Siegmund Karasch
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Deutsche Biotech Innovativ AG
Deutsche Biotech Innovativ AG Financial ConglomeratesFinance Invests in companies which are involved in innovative business concepts and technologies | Finance |
AdrenoMed AG
AdrenoMed AG Pharmaceuticals: MajorHealth Technology Develops a drug to decrease mortality in severe sepsis | Health Technology |
Hochschule für Technik und Wirtschaft Berlin
Hochschule für Technik und Wirtschaft Berlin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
InVivo BioTech Services GmbH
InVivo BioTech Services GmbH Medical SpecialtiesHealth Technology Manufactures analytical and medical instruments | Health Technology |
















